NEXGARD SPECTRA 150 MG / 30 MG COMPRIMÉS À CROQUER POUR CHIENS > 30 - 60 KG.

About this veterinary medicine

NEXGARD SPECTRA 150 MG / 30 MG COMPRIMÉS À CROQUER POUR CHIENS > 30 - 60 KG. is a veterinary medicine in the form of comprimé à croquer containing afoxolaner+milbemycine oxime, intended for the following species: dog. It is marketed by BOEHRINGER INGELHEIM VETMEDICA GmbH. It holds a marketing authorisation in Tunisia under number 101.1596.24.

Characteristics

Form

Comprimé à croquer

Strength

150 mg/ 30 mg.

Presentation

Boîte de 1 plaquette de 3 comprimés à croquer.

Route of administration

Oral route

Laboratory

BOEHRINGER INGELHEIM VETMEDICA GmbH

Country

Germany

Target species

Dog

Regulatory status — Tunisie

🟢 Marketing authorisation in force

Authorisation no. : 101.1596.24 — Authorisation date : 06/12/2024

⚠️ Regulatory alerts

No alert reported.

📦 Availability in Tunisia

Reported by TunisieVet veterinarians.

🔒 Availability reporting is reserved for signed-in veterinarians.